The human glucocorticoid receptor: Molecular basis of biologic function

Clark, 1992, Mechanism of steroid hormones, 35

Chrousos, 2004, Glucocorticoid action networks—an introduction to systems biology, J Clin Endocrinol Metab, 89, 563, 10.1210/jc.2003-032026

Chrousos, 2004, The glucocorticoid receptor gene, longevity, and the complex disorders of Western societies, Am J Med, 117, 204, 10.1016/j.amjmed.2004.05.006

Galon, 2002, Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells, FASEB J, 16, 61, 10.1096/fj.01-0245com

Zhou, 2005, The human glucocorticoid receptor: one gene, multiple proteins and diverse responses, Steroids, 70, 407, 10.1016/j.steroids.2005.02.006

Duma, 2006, Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification, J Steroid Biochem Mol Biol, 102, 11, 10.1016/j.jsbmb.2006.09.009

Hollenberg, 1985, Primary structure and expression of a functional human glucocorticoid receptor cDNA, Nature, 318, 635, 10.1038/318635a0

Kino, 2009, Glucocorticoid receptor (GR) β has intrinsic, GRα-independent transcriptional activity, Biochem Biophys Res Commun, 381, 671, 10.1016/j.bbrc.2009.02.110

Oakley, 1999, The dominant negative activity of the human glucocorticoid receptor β isoform. Specificity and mechanisms of action, J Biol Chem, 274, 27857, 10.1074/jbc.274.39.27857

Bledsoe, 2002, Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition, Cell, 110, 93, 10.1016/S0092-8674(02)00817-6

Tanenbaum, 1998, Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains, Proc Natl Acad Sci USA, 95, 5998, 10.1073/pnas.95.11.5998

Kauppi, 2003, The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism, J Biol Chem, 278, 22748, 10.1074/jbc.M212711200

Zhang, 1996, Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination, Mol Endocrinol, 10, 24, 10.1210/me.10.1.24

Robin-Jagerschmidt, 2000, Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity, Mol Endocrinol, 14, 1028, 10.1210/me.14.7.1028

Rogerson, 2007, A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors, Mol Endocrinol, 21, 817, 10.1210/me.2006-0246

Charmandari, 2005, A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity, J Clin Endocrinol Metab, 90, 3696, 10.1210/jc.2004-1920

Lu, 2005, Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes, Mol Cell, 18, 331, 10.1016/j.molcel.2005.03.025

Breslin, 2001, Multiple promoters exist in the human GR gene, one of which is activated by glucocorticoids, Mol Endocrinol, 15, 1381, 10.1210/me.15.8.1381

Chrousos, 2005, Intracellular glucocorticoid signaling: a formerly simple system turns stochastic, Sci STKE, 2005, pe48, 10.1126/stke.3042005pe48

Pratt, 1993, The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor, J Biol Chem, 268, 21455, 10.1016/S0021-9258(20)80556-0

Davies, 2002, A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins, J Biol Chem, 277, 4597, 10.1074/jbc.C100531200

Brown, 1970, Pituitary–adrenal function in the squirrel monkey, Endocrinology, 86, 519, 10.1210/endo-86-3-519

Denny, 2000, Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding, Endocrinology, 141, 4107, 10.1210/en.141.11.4107

Terry, 2007, Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport, Science, 318, 1412, 10.1126/science.1142204

Bamberger, 1996, Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids, Endocr Rev, 17, 245, 10.1210/edrv-17-3-245

Schaaf, 2002, Molecular mechanisms of glucocorticoid action and resistance, J Steroid Biochem Mol Biol, 83, 37, 10.1016/S0960-0760(02)00263-7

Jonat, 1990, Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone, Cell, 62, 1189, 10.1016/0092-8674(90)90395-U

Scheinman, 1995, Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors, Mol Cell Biol, 15, 943, 10.1128/MCB.15.2.943

Kino, 2002, Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: multifactorial states of clinical importance, J Allergy Clin Immunol, 109, 609, 10.1067/mai.2002.123708

Gottlicher, 1998, Transcriptional crosstalk, the second mode of steroid hormone receptor action, J Mol Med, 76, 480, 10.1007/s001090050242

Jonat, 1990, Anti-tumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone, Cell, 62, 1189, 10.1016/0092-8674(90)90395-U

Schule, 1990, Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor, Cell, 62, 1217, 10.1016/0092-8674(90)90397-W

Konig, 1992, Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo, EMBO J, 11, 2241, 10.1002/j.1460-2075.1992.tb05283.x

Heck, 1994, A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1, EMBO J, 13, 4087, 10.1002/j.1460-2075.1994.tb06726.x

McKay, 1999, Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways, Endocr Rev, 20, 435, 10.1210/er.20.4.435

Stocklin, 1996, Functional interactions between Stat5 and the glucocorticoid receptor, Nature, 383, 726, 10.1038/383726a0

Liu, 2000, Protracted nuclear export of glucocorticoid receptor limits its turnover and does not require the exportin 1/CRM1-directed nuclear export pathway, Mol Endocrinol, 14, 40, 10.1210/me.14.1.40

Carrigan, 2007, An active nuclear retention signal in the glucocorticoid receptor functions as a strong inducer of transcriptional activation, J Biol Chem, 282, 10963, 10.1074/jbc.M602931200

Black, 2001, DNA binding domains in diverse nuclear receptors function as nuclear export signals, Curr Biol, 11, 1749, 10.1016/S0960-9822(01)00537-1

Holaska, 2002, Ca2+-dependent nuclear export mediated by calreticulin, Mol Cell Biol, 22, 6286, 10.1128/MCB.22.17.6286-6297.2002

Lieberman, 1993, The constitution of a progesterone response element, Mol Endocrinol, 7, 515, 10.1210/me.7.4.515

Beato, 1996, Interaction of steroid hormone receptors with the transcription initiation complex, Endocr Rev, 17, 587, 10.1210/edrv-17-6-587

McKenna, 1999, Nuclear receptor coregulators: cellular and molecular biology, Endocr Rev, 20, 321, 10.1210/er.20.3.321

McKenna, 1999, Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions, J Steroid Biochem Mol Biol, 69, 3, 10.1016/S0960-0760(98)00144-7

McKenna, 2002, Combinatorial control of gene expression by nuclear receptors and coregulators, Cell, 108, 465, 10.1016/S0092-8674(02)00641-4

Auboeuf, 2002, Coordinate regulation of transcription and splicing by steroid receptor coregulators, Science, 298, 416, 10.1126/science.1073734

Heery, 1997, A signature motif in transcriptional co-activators mediates binding to nuclear receptors, Nature, 387, 733, 10.1038/42750

Reichardt, 1998, DNA binding of the glucocorticoid receptor is not essential for survival, Cell, 93, 531, 10.1016/S0092-8674(00)81183-6

Cole, 1995, Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation, Genes Dev, 9, 1608, 10.1101/gad.9.13.1608

Reichardt, 2001, Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor, EMBO J, 20, 7168, 10.1093/emboj/20.24.7168

Karin, 2001, AP-1-glucocorticoid receptor crosstalk taken to a higher level, J Endocrinol, 169, 447, 10.1677/joe.0.1690447

Barnes, 1997, Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases, N Engl J Med, 336, 1066, 10.1056/NEJM199704103361506

Didonato, 1996, Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids, Am J Respir Crit Care Med, 154, S11, 10.1164/ajrccm/154.2_Pt_2.S11

Ismaili, 2004, Modulation of glucocorticoid receptor function via phosphorylation, Ann N Y Acad Sci, 1024, 86, 10.1196/annals.1321.007

Orti, 1993, Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors, J Biol Chem, 268, 7779, 10.1016/S0021-9258(18)53026-X

Wang, 2002, Deciphering the phosphorylation “code” of the glucocorticoid receptor in vivo, J Biol Chem, 277, 26573, 10.1074/jbc.M110530200

Miller, 2005, p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211, Mol Endocrinol, 19, 1569, 10.1210/me.2004-0528

Kino, 2007, Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress, Mol Endocrinol, 21, 1552, 10.1210/me.2006-0345

Rogatsky, 1998, Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation, J Biol Chem, 273, 14315, 10.1074/jbc.273.23.14315

Galliher-Beckley, 2008, Glycogen synthase kinase 3β-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles, Mol Cell Biol, 28, 7309, 10.1128/MCB.00808-08

Rogatsky, 1998, Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase, Proc Natl Acad Sci USA, 95, 2050, 10.1073/pnas.95.5.2050

Itoh, 2002, Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation, Mol Endocrinol, 16, 2382, 10.1210/me.2002-0144

Dennis, 2005, Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription, J Steroid Biochem Mol Biol, 93, 139, 10.1016/j.jsbmb.2004.12.015

Kinyamu, 2005, Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors, J Mol Endocrinol, 34, 281, 10.1677/jme.1.01680

Gillette, 2004, Physical and functional association of RNA polymerase II and the proteasome, Proc Natl Acad Sci USA, 101, 5904, 10.1073/pnas.0305411101

Deroo, 2002, Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking, Mol Cell Biol, 22, 4113, 10.1128/MCB.22.12.4113-4123.2002

Kino, 2004, Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function, Mol Med, 10, 80, 10.2119/2005-00026.Kino

Ito, 2006, Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression, J Exp Med, 203, 7, 10.1084/jem.20050466

Nader, 2009, Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications, FASEB J, 23, 1572, 10.1096/fj.08-117697

Le Drean, 2002, Potentiation of glucocorticoid receptor transcriptional activity by sumoylation, Endocrinology, 143, 3482, 10.1210/en.2002-220135

Göttlicher, 1996, Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor, Steroids, 61, 257, 10.1016/0039-128X(96)00032-3

Cho, 2005, Glucocorticoid receptor ligand binding domain is sufficient for the modulation of glucocorticoid induction properties by homologous receptors, coactivator transcription intermediary factor 2, and Ubc9, Mol Endocrinol, 19, 290, 10.1210/me.2004-0134

Tian, 2002, Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor, Biochem J, 367, 907, 10.1042/bj20021085

Holmstrom, 2003, Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy, Proc Natl Acad Sci USA, 100, 15758, 10.1073/pnas.2136933100

Kino, 2001, Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes, J Endocrinol, 169, 437, 10.1677/joe.0.1690437

Chrousos, 2002, Hormone resistance and hypersensitivity states, 542

Kino, 2003, Tissue glucocorticoid resistance/hypersensitivity syndromes, J Steroid Biochem Mol Biol, 85, 457, 10.1016/S0960-0760(03)00218-8

Chrousos, 2007, Glucocorticoid action networks and complex psychiatric and/or somatic disorders, Stress, 10, 213, 10.1080/10253890701292119

Vingerhoeds, 1976, Spontaneous hypercortisolism without Cushing's syndrome, J Clin Endocrinol Metab, 43, 1128, 10.1210/jcem-43-5-1128

Chrousos, 1982, Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease, J Clin Invest, 69, 1261, 10.1172/JCI110565

Chrousos, 1993, Syndromes of glucocorticoid resistance, Ann Intern Med, 119, 1113, 10.7326/0003-4819-119-11-199312010-00009

Kino, 2002, Familial/sporadic glucocorticoid resistance syndrome and hypertension, Ann N Y Acad Sci, 970, 101, 10.1111/j.1749-6632.2002.tb04416.x

Charmandari, 2004, Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms, Ann N Y Acad Sci, 1024, 168, 10.1196/annals.1321.014

Charmandari, 2007, Novel causes of generalized glucocorticoid resistance, Horm Metab Res, 39, 445, 10.1055/s-2007-980196

Charmandari, 2008, Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder, J Clin Endocrinol Metab, 93, 1563, 10.1210/jc.2008-0040

Karl, 1996, Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation, Proc Assoc Am Physicians, 108, 296

Hurley, 1991, Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance, J Clin Invest, 87, 680, 10.1172/JCI115046

Karl, 1993, Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene, J Clin Endocrinol Metab, 76, 683, 10.1210/jc.76.3.683

Malchoff, 1993, A mutation of the glucocorticoid receptor in primary cortisol resistance, J Clin Invest, 91, 1918, 10.1172/JCI116410

Kino, 2001, Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking, J Clin Endocrinol Metab, 86, 5600, 10.1210/jc.86.11.5600

Ruiz, 2001, Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance, Clin Endocrinol (Oxf), 55, 363, 10.1046/j.1365-2265.2001.01323.x

Mendonca, 2002, Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene, J Clin Endocrinol Metab, 87, 1805, 10.1210/jc.87.4.1805

Vottero, 2002, A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators, J Clin Endocrinol Metab, 87, 2658, 10.1210/jc.87.6.2658

Charmandari, 2004, Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission and clinical phenotype, J Clin Endocrinol Metab, 89, 1939, 10.1210/jc.2003-030450

Charmandari, 2006, Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRαR477H and hGRαG679S associated with generalized glucocorticoid resistance, J Clin Endocrinol Metab, 91, 1535, 10.1210/jc.2005-1893

Charmandari, 2007, A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance, J Clin Endocrinol Metab, 92, 3986, 10.1210/jc.2006-2830

Savory, 1999, Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor, Mol Cell Biol, 19, 1025, 10.1128/MCB.19.2.1025

Picard, 1987, Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor, EMBO J, 6, 3333, 10.1002/j.1460-2075.1987.tb02654.x

Qi, 1989, v-mos oncoproteins affect the nuclear retention and reutilization of glucocorticoid receptors, Mol Endocrinol, 3, 1279, 10.1210/mend-3-8-1279

Wikstrom, 1987, Intracellular localization of the glucocorticoid receptor: evidence for cytoplasmic and nuclear localization, Endocrinology, 120, 1232, 10.1210/endo-120-4-1232

Ding, 1998, Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities, Mol Endocrinol, 12, 302, 10.1210/me.12.2.302

Hong, 1997, GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors, Mol Cell Biol, 17, 2735, 10.1128/MCB.17.5.2735

Hong, 1996, GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors, Proc Natl Acad Sci USA, 93, 4948, 10.1073/pnas.93.10.4948

Lamberts, 1996, Clinical aspects of glucocorticoid sensitivity, Steroids, 61, 157, 10.1016/0039-128X(96)00005-0

Smit, 2005, Differential regulation of synthetic glucocorticoids on gene expression levels of glucocorticoid-induced leucine zipper and interleukin-2, J Clin Endocrinol Metab, 90, 2994, 10.1210/jc.2004-2298

van Rossum, 2004, Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition, Recent Prog Horm Res, 59, 333, 10.1210/rp.59.1.333

Koper, 1997, Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance, Hum Genet, 99, 663, 10.1007/s004390050425

Huizenga, 1998, A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo, J Clin Endocrinol Metab, 83, 144, 10.1210/jc.83.1.144

Lin, 2003, Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant, Obes Res, 11, 802, 10.1038/oby.2003.111

Di Blasio, 2003, The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients, Clin Endocrinol (Oxf), 59, 68, 10.1046/j.1365-2265.2003.01798.x

Roussel, 2003, The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus, Clin Endocrinol (Oxf), 59, 237, 10.1046/j.1365-2265.2003.01831.x

Dobson, 2001, The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus, J Clin Endocrinol Metab, 86, 2270, 10.1210/jc.86.5.2270

Lin, 2003, Association of coronary artery disease with glucocorticoid receptor N363S variant, Hypertension, 41, 404, 10.1161/01.HYP.0000055342.40301.DC

Buemann, 1997, Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus, Obes Res, 5, 186, 10.1002/j.1550-8528.1997.tb00292.x

Rosmond, 2000, A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic–pituitary–adrenal axis, Obes Res, 8, 211, 10.1038/oby.2000.24

Ukkola, 2001, Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Québec Family Study, Int J Obes Relat Metab Disord, 25, 1332, 10.1038/sj.ijo.0801735

Weaver, 1992, An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women, J Mol Endocrinol, 9, 295, 10.1677/jme.0.0090295

van Rossum, 2003, Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index, Clin Endocrinol (Oxf), 59, 585, 10.1046/j.1365-2265.2003.01888.x

Russcher, 2005, Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression, J Clin Endocrinol Metab, 90, 5804, 10.1210/jc.2005-0646

van Rossum, 2002, A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels, Diabetes, 51, 3128, 10.2337/diabetes.51.10.3128

van Rossum, 2004, Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men, Am J Med, 117, 158, 10.1016/j.amjmed.2004.01.027

van Rossum, 2004, The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults, J Clin Endocrinol Metab, 89, 4004, 10.1210/jc.2003-031422

Russcher, 2005, Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism, Mol Endocrinol, 19, 1687, 10.1210/me.2004-0467

Detera-Wadleigh, 1991, A TthIII1 polymorphism on the 5′ flanking region of the glucocorticoid receptor gene (GRL), Nucleic Acids Res, 19, 1960, 10.1093/nar/19.8.1960-a

van Rossum, 2004, Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms, Clin Endocrinol (Oxf), 61, 573, 10.1111/j.1365-2265.2004.02132.x

Charmandari, 2008, A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression, J Clin Endocrinol Metab, 93, 4963, 10.1210/jc.2008-0892

Syed, 2006, Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women, Obesity (Silver Spring), 14, 759, 10.1038/oby.2006.86